Datavant, a Phoenix, AZ-based well being knowledge platform firm, accomplished the acquisition of Aetion, a real-world proof (RWE) platform that powers vital decision-making in healthcare.
The quantity of the deal was not disclosed.
Aetion is now a part of Datavant’s Life Sciences enterprise. With the completion of this acquisition, Datavant is positioned to ship an end-to-end platform for knowledge feasibility and evaluation, enabling healthcare and life sciences firms to extra effectively reply analysis questions in regards to the scientific influence of therapies in growth and in market.
Datavant and Aetion have a mixed ecosystem of over 300 knowledge companions comprising datasets and insights throughout digital well being information, claims, specialty pharmacy, registries, imaging, lab, social determinants of well being, and extra.
Aetion is a worldwide healthcare know-how firm that delivers real-world proof (RWE) options to biopharmaceutical firms, medical system producers, payers, and regulators. It applies superior causal inference, rigorous epidemiologic strategies, and purpose-built AI to remodel advanced healthcare knowledge into clear, dependable proof on the security, effectiveness, and worth of medical therapies. Via this evidence-based strategy, Aetion informs healthcare’s most crucial choices—what works finest, for whom, and when—whereas enabling scalable options for regulatory submissions, market entry, and scientific growth. Aetion’s buyers embody Flare Capital Companions, NEA, Warburg Pincus, B Capital, and life sciences and payer organizations.
Led by Kyle Armbrester, CEO, Datavant is a well being knowledge platform firm that makes well being knowledge safe, accessible, and actionable. It allows greater than 60 million healthcare information to maneuver between 1000’s of organizations, greater than 80,000 hospitals and clinics, 75% of the 100 largest well being programs, and an ecosystem of 300+ real-world knowledge companions.
FinSMEs
12/07/2025
